SEC Form 4 · accession 0001225208-15-000611
WEST PHARMACEUTICAL SERVICES INC · WST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Anthony Welters
Director
Period of report
Dec 31, 2014
Accepted (ET)
Jan 5, 2015 · 7:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000105770
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Phantom Stock UnitF2,F1 | — | Dec 31, 2014 | A | 325 | A | — | — | Common Stock | 325 | 59,962 | D |
Explanation of responses
- F1Awards of phantom stock units are to be settled only in cash upon the reporting person's termination as a director.
- F2Reflects additional Phantom Stock Units credited through dividend reinvestment based on most recent plan statement.